| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2022 | 270.37% | Maxim Group | → $8 | Initiates Coverage On | → Buy |
| 08/08/2022 | 270.37% | Benchmark | → $8 | Initiates Coverage On | → Speculative Buy |
Heart Test Laboratories Questions & Answers
The latest price target for Heart Test Laboratories (NASDAQ: HSCS) was reported by Maxim Group on November 9, 2022. The analyst firm set a price target for $8.00 expecting HSCS to rise to within 12 months (a possible 270.37% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Heart Test Laboratories (NASDAQ: HSCS) was provided by Maxim Group, and Heart Test Laboratories initiated their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Heart Test Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Heart Test Laboratories was filed on November 9, 2022 so you should expect the next rating to be made available sometime around November 9, 2023.
While ratings are subjective and will change, the latest Heart Test Laboratories (HSCS) rating was a initiated with a price target of $0.00 to $8.00. The current price Heart Test Laboratories (HSCS) is trading at is $2.16, which is within the analyst's predicted range.